Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $9.0150 (-2.12%) ($9.0150 - $9.0150) on Fri. Jan. 21, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 35 | Latest Price | $9.0150(-2.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -2% a day on average for past five trading days. | Weekly Trend | FOLD declines -11.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(64%) IWO(54%) IWM(51%) IWC(50%) XBI(49%) | Factors Impacting FOLD price | FOLD will decline at least -2.105% in a week (0% probabilities). VIXM(-30%) VXX(-13%) UUP(-13%) UNG(-7%) USO(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.25(-213.7%) | Resistance Level | $10.84 | 5 Day Moving Average | $9.54(-5.5%) | 10 Day Moving Average | $9.78(-7.82%) | 20 Day Moving Average | $10.84(-16.84%) | To recent high | -27.6% | To recent low | 0% | Market Cap | $2.328b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |